Budget impact of GCSF biosimilarsResearch Project | 15.01.2020 - 30.06.2020 Budget impact of GCSF biosimilars in Switzerland, for different pricing strategies/assumptions.FundingBudget impact of GCSF biosimilarsMundipharma, 01.2020-04.2020 (4) PI : Schwenkglenks, Matthias.Members (1) Matthias SchwenkglenksPrincipal InvestigatorResearch Groups[FG] European Center for Pharmaceutical Medicine (ECPM)Pharmazeutische Medizin (Szucs)
FundingBudget impact of GCSF biosimilarsMundipharma, 01.2020-04.2020 (4) PI : Schwenkglenks, Matthias.
Research Groups[FG] European Center for Pharmaceutical Medicine (ECPM)Pharmazeutische Medizin (Szucs)